These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38095070)

  • 21. Seroprevalence study in forestry workers from eastern Germany using novel genotype 3- and rat hepatitis E virus-specific immunoglobulin G ELISAs.
    Dremsek P; Wenzel JJ; Johne R; Ziller M; Hofmann J; Groschup MH; Werdermann S; Mohn U; Dorn S; Motz M; Mertens M; Jilg W; Ulrich RG
    Med Microbiol Immunol; 2012 May; 201(2):189-200. PubMed ID: 22179131
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High prevalence of anti-hepatitis E virus antibodies among blood donors in central Italy, February to March 2014.
    Lucarelli C; Spada E; Taliani G; Chionne P; Madonna E; Marcantonio C; Pezzotti P; Bruni R; La Rosa G; Pisani G; Dell'Orso L; Ragone K; Tomei C; Ciccaglione AR
    Euro Surveill; 2016 Jul; 21(30):. PubMed ID: 27494608
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk of hepatitis-E virus infections among blood donors in a regional blood transfusion centre in western India.
    Mishra KK; Patel K; Trivedi A; Patel P; Ghosh K; Bharadva S
    Transfus Med; 2021 Jun; 31(3):193-199. PubMed ID: 33738857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis E virus infection in HIV-infected patients with elevated serum transaminases levels.
    Sellier P; Mazeron MC; Tesse S; Badsi E; Evans J; Magnier JD; Sanson-Le-Pors MJ; Bergmann JF; Nicand E
    Virol J; 2011 Apr; 8():171. PubMed ID: 21496215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A small animal model of chronic hepatitis E infection using immunocompromised rats.
    Sridhar S; Wu S; Situ J; Shun EH; Li Z; Zhang AJ; Hui K; Fong CH; Poon VK; Chew NF; Yip CC; Chan WM; Cai JP; Yuen KY
    JHEP Rep; 2022 Oct; 4(10):100546. PubMed ID: 36052220
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Seroprevalence of hepatitis E virus in patients with hepatitis C and / or infected with HIV].
    López-Fabal MF; Gómez-Garcés JL
    Rev Esp Quimioter; 2015 Dec; 28(6):314-6. PubMed ID: 26621176
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serological and molecular study of Hepatitis E virus in pediatric patients in Mexico.
    López-Santaella T; Álvarez Y Muñoz T; Medeiros-Domingo M; Moreno-Espinosa S; Consuelo-Sánchez A; Muñoz-Hernández O; Sarmiento-Silva RE; Sotomayor-González A; Trujillo-Ortega ME; García-Hernández ME; Taboada-Ramírez BI; Arenas-Huertero F
    Ann Hepatol; 2020; 19(3):295-301. PubMed ID: 31899127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Seroprevalence of Hepatitis E virus in children and adolescents living in urban Bogotá: An explorative cross-sectional study.
    Fernández Villalobos NV; Kessel B; Torres Páez JC; Strömpl J; Kerrinnes T; de la Hoz Restrepo FP; Strengert M; Krause G
    Front Public Health; 2023; 11():981172. PubMed ID: 36844812
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    Benavent S; Carlos S; Reina G
    Microorganisms; 2023 Dec; 11(12):. PubMed ID: 38138140
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Production of monoclonal antibodies against the ORF3 protein of rat hepatitis E virus (HEV) and demonstration of the incorporation of the ORF3 protein into enveloped rat HEV particles.
    Takahashi M; Kobayashi T; Tanggis ; Jirintai S; Mulyanto ; Nagashima S; Nishizawa T; Kunita S; Okamoto H
    Arch Virol; 2016 Dec; 161(12):3391-3404. PubMed ID: 27638774
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis E in hemodialysis and kidney transplant patients in south-east Italy.
    Scotto G; Aucella F; Grandaliano G; Martinelli D; Querques M; Gesuete A; Infante B; Carri PD; Massa S; Salatino G; Bulla F; Fazio V
    World J Gastroenterol; 2015 Mar; 21(11):3266-73. PubMed ID: 25805933
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of antibodies to hepatitis E virus among Japanese blood donors: identification of three blood donors infected with a genotype 3 hepatitis E virus.
    Fukuda S; Sunaga J; Saito N; Fujimura K; Itoh Y; Sasaki M; Tsuda F; Takahashi M; Nishizawa T; Okamoto H
    J Med Virol; 2004 Aug; 73(4):554-61. PubMed ID: 15221899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Orthohepevirus C infection as an emerging cause of acute hepatitis in Spain: First report in Europe.
    Rivero-Juarez A; Frias M; Perez AB; Pineda JA; Reina G; Fuentes-Lopez A; Freyre-Carrillo C; Ramirez-Arellano E; Alados JC; Rivero A;
    J Hepatol; 2022 Aug; 77(2):326-331. PubMed ID: 35167911
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIV, HEV and cirrhosis: evidence of a possible link from eastern Spain.
    Jardi R; Crespo M; Homs M; van den Eynde E; Girones R; Rodriguez-Manzano J; Caballero A; Buti M; Esteban R; Rodriguez-Frias F
    HIV Med; 2012 Jul; 13(6):379-83. PubMed ID: 22257075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis E Virus Seroprevalence and Correlates of Anti-HEV IgG Antibodies in the Rakai District, Uganda.
    Boon D; Redd AD; Laeyendecker O; Engle RE; Nguyen H; Ocama P; Boaz I; Ndyanabo A; Kiggundu V; Reynolds SJ; Gray RH; Wawer MJ; Purcell RH; Kirk GD; Quinn TC; Stabinski L;
    J Infect Dis; 2018 Feb; 217(5):785-789. PubMed ID: 29186448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis E 3ra Genotype Infection in People Living With HIV in Spain.
    Rivero-Juarez A; Frias M; Lopez-Lopez P; Berenguer J; García F; Macias J; Alcaraz B; Castro-Iglesias A; Caballero-Gomez J; Rivero A
    Front Microbiol; 2020; 11():564486. PubMed ID: 33716992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of hepatitis E virus RNA and antibodies in a cohort of kidney transplant recipients in Central Brazil.
    de Oliveira JMNS; Freitas NR; Teles SA; Bottino FO; Lemos AS; de Oliveira JM; de Paula V; Pinto MA; Martins RMB
    Int J Infect Dis; 2018 Apr; 69():41-43. PubMed ID: 29408465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detailed investigation of ongoing subclinical hepatitis E virus infections; occurring in outbreak settings of North India.
    Majumdar M; Singh MP; Goyal K; Chawla Y; Ratho RK
    Liver Int; 2015 Mar; 35(3):826-33. PubMed ID: 24750588
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ongoing subclinical infection of hepatitis E virus among blood donors with an elevated alanine aminotransferase level in Japan.
    Gotanda Y; Iwata A; Ohnuma H; Yoshikawa A; Mizoguchi H; Endo K; Takahashi M; Okamoto H
    J Med Virol; 2007 Jun; 79(6):734-42. PubMed ID: 17457924
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Special Risk Group for Hepatitis E Infection: The First Record of North Cyprus.
    Süer K; Güvenir M; Aykaç A
    Pol J Microbiol; 2018; 67(4):525-528. PubMed ID: 30550239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.